1.53
前日終値:
$1.66
開ける:
$1.63
24時間の取引高:
940.47K
Relative Volume:
1.15
時価総額:
$163.11M
収益:
$45.44M
当期純損益:
$-35.43M
株価収益率:
-4.50
EPS:
-0.34
ネットキャッシュフロー:
$-25.39M
1週間 パフォーマンス:
-5.56%
1か月 パフォーマンス:
+10.07%
6か月 パフォーマンス:
-50.65%
1年 パフォーマンス:
-59.84%
Maxcyte Inc Stock (MXCT) Company Profile
MXCT を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
MXCT
Maxcyte Inc
|
1.53 | 176.97M | 45.44M | -35.43M | -25.39M | -0.34 |
![]()
ABT
Abbott Laboratories
|
133.31 | 233.03B | 43.11B | 13.94B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
98.14 | 145.30B | 18.49B | 2.50B | 3.49B | 1.68 |
![]()
SYK
Stryker Corp
|
368.57 | 141.92B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
MDT
Medtronic Plc
|
94.30 | 122.80B | 34.20B | 4.69B | 5.30B | 3.63 |
![]()
EW
Edwards Lifesciences Corp
|
75.27 | 43.83B | 5.69B | 1.41B | 577.90M | 6.95 |
Maxcyte Inc Stock (MXCT) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-08-11 | ダウングレード | BTIG Research | Buy → Neutral |
2025-08-07 | ダウングレード | William Blair | Outperform → Mkt Perform |
2025-07-22 | 開始されました | Stephens | Overweight |
2023-11-29 | 開始されました | Craig Hallum | Buy |
2021-10-15 | 再開されました | Cowen | Outperform |
2021-08-24 | 開始されました | BTIG Research | Buy |
2021-08-24 | 開始されました | Cowen | Outperform |
2021-08-24 | 開始されました | Stephens | Overweight |
2021-08-24 | 開始されました | Stifel | Buy |
2021-08-24 | 開始されました | Wedbush | Outperform |
2021-08-24 | 開始されました | William Blair | Outperform |
すべてを表示
Maxcyte Inc (MXCT) 最新ニュース
Pattern recognition hints at MaxCyte Inc. upsideSell Signal & Expert Approved Trade Ideas - newser.com
Goldman Sachs Group Inc. Trims Holdings in MaxCyte, Inc. $MXCT - MarketBeat
Is MaxCyte Inc. building a consolidation baseMarket Risk Summary & Capital Efficient Trading Techniques - newser.com
Rockville's MaxCyte slashes workforce by 34% amid revenue struggles - The Business Journals
MaxCyte Announces Major Workforce Reduction Plan - TipRanks
MaxCyte to Downsize Workforce by 34% as Part of Operational Restructuring - MarketScreener
MaxCyte, Inc. Announces Workforce Reduction and Operational Restructuring to Enhance Profitability - Quiver Quantitative
Maxcyte announces operational restructuring to reduce costs - MarketScreener
MaxCyte Announces Operational Restructuring to Reduce Costs and Accelerate Path to Profitability - Enidnews.com
34% Workforce Reduction: MaxCyte's $13.6M Cost-Cutting Plan Aims to Accelerate Path to Profitability - Stock Titan
Is now a turning point for MaxCyte Inc.July 2025 Technicals & Fast Momentum Stock Entry Tips - newser.com
Tick level data insight on MaxCyte Inc. volatilityWeekly Trade Recap & High Accuracy Investment Entry Signals - newser.com
How to use a screener to detect MaxCyte Inc. breakoutsJuly 2025 Pullbacks & Pattern Based Trade Signal System - newser.com
Intraday pattern recognizer results for MaxCyte Inc.Trade Analysis Summary & Real-Time Price Movement Reports - newser.com
Is MaxCyte Inc. showing signs of accumulationIndex Update & Safe Entry Zone Tips - newser.com
Swedbank AB Sells 210,000 Shares of MaxCyte, Inc. $MXCT - MarketBeat
Swing Trade: Why is MaxCyte Inc stock going downWeekly Risk Report & Safe Capital Investment Plans - خودرو بانک
US Market Recap: How volatile is MaxCyte Inc stock2025 Top Decliners & Low Risk Profit Maximizing Plans - khodrobank.com
MaxCyte Inc. stock trend forecast2025 Key Lessons & Step-by-Step Trade Execution Guides - newser.com
Can MaxCyte Inc. rally from current levelsEarnings Recap Report & Entry Point Confirmation Alerts - newser.com
Market Fear: Does MaxCyte Inc. have a sustainable dividendJuly 2025 Macro Moves & Real-Time Chart Pattern Alerts - خودرو بانک
Can machine learning forecast MaxCyte Inc. recovery2025 AllTime Highs & Real-Time Chart Breakout Alerts - newser.com
How to forecast MaxCyte Inc. trends using time seriesQuarterly Profit Summary & Long-Term Capital Growth Ideas - newser.com
MaxCyte Inc. stock prediction for this weekTrend Reversal & Weekly Setup with High ROI Potential - newser.com
Fed Watch: Will MaxCyte Inc benefit from rising consumer demandJuly 2025 Action & Long Hold Capital Preservation Tips - خودرو بانک
What to do if you’re stuck in MaxCyte Inc.2025 Geopolitical Influence & Daily Chart Pattern Signals - newser.com
MaxCyte Inc. stock daily chart insightsBond Market & Long Hold Capital Preservation Tips - newser.com
Using portfolio simulators with MaxCyte Inc. includedPrice Action & Real-Time Volume Trigger Notifications - newser.com
MaxCyte Inc.’s volatility index tracking explainedWeekly Trade Analysis & Weekly High Conviction Ideas - newser.com
Winners Losers: How does MaxCyte Inc. score in quality rankingsJuly 2025 Technicals & Trade Opportunity Analysis Reports - خودرو بانک
Aug Setups: Is MaxCyte Inc. a top pick in the sectorJuly 2025 Levels & Weekly High Potential Stock Alerts - خودرو بانک
Is MaxCyte Inc. stock reversal real or fakeStop Loss & Proven Capital Preservation Tips - newser.com
What are MaxCyte Incs recent SEC filings showingJuly 2025 Reactions & Weekly High Return Opportunities - خودرو بانک
Trade Recap: Is MaxCyte Inc stock a value trapDip Buying & High Conviction Trade Alerts - خودرو بانک
Weekly Trades: Can MaxCyte Inc. disrupt its industryPortfolio Value Summary & Advanced Technical Signal Analysis - خودرو بانک
Does MaxCyte Inc. have a sustainable dividendEarnings Recap Report & Risk Adjusted Buy and Sell Alerts - خودرو بانک
Insider Trends: Is MaxCyte Inc a top pick in the sectorMarket Rally & Long-Term Capital Growth Strategies - خودرو بانک
Guidance Update: Will PINS benefit from AI trendsWeekly Market Report & Free Reliable Trade Execution Plans - خودرو بانک
Stock Analysis: Is MaxCyte Inc stock risky to hold nowWall Street Watch & Risk Managed Investment Entry Signals - خودرو بانک
Trend Report: What is the next catalyst for MaxCyte IncJuly 2025 Patterns & High Conviction Investment Ideas - خودرو بانک
MaxCyte signs platform license agreement with Adicet Bio - MSN
Maxcyte Inc (MXCT) 財務データ
収益
当期純利益
現金流量
EPS
Maxcyte Inc (MXCT) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Swirsky Douglas J | CHIEF FINANCIAL OFFICER |
Aug 13 '25 |
Buy |
1.29 |
50,000 |
64,500 |
161,811 |
Masoud Maher | President and CEO |
Aug 13 '25 |
Buy |
1.37 |
75,000 |
102,915 |
175,000 |
Erck Stanley C | Director |
Aug 13 '25 |
Buy |
1.37 |
100,000 |
137,220 |
398,328 |
DOUGLAS RICHARD | Director |
Aug 13 '25 |
Buy |
1.39 |
80,000 |
111,040 |
230,577 |
Brooke William W | Director |
Aug 13 '25 |
Buy |
1.29 |
50,000 |
64,500 |
150,879 |
大文字化:
|
ボリューム (24 時間):